Mia's Feed
Medical News & Research

Unlocking Longevity: How Dolphin Arteries Remain Young and What It Means for Human Heart Health

Unlocking Longevity: How Dolphin Arteries Remain Young and What It Means for Human Heart Health

Share this article

Exploring how dolphins' arteries avoid aging offers promising insights for preventing cardiovascular diseases in humans. Groundbreaking research reveals the potential of dolphin blood factors in maintaining arterial health and aging prevention.

2 min read

Scientists are investigating the remarkable resilience of dolphin arteries as they age, aiming to uncover insights that could revolutionize cardiovascular health in humans. Research led by Yara Bernaldo de Quirós, a biologist at the University of Las Palmas de Gran Canaria, explores why dolphins do not develop age-related arterial diseases like atherosclerosis, despite their long lifespans. This curiosity arose during her Ph.D. studies on large whales, which surprisingly do not suffer from arterial aging issues, possibly due to adaptations from deep diving behaviors that cause rapid blood flow and oxygen fluctuations.

To test these ideas, Bernaldo de Quirós collaborated with Professor Douglas Seals from the University of Colorado Boulder in a project called Arterial Aging. They hypothesized that marine mammals, through millions of years of evolution to withstand extreme pressures, developed natural mechanisms protecting their arteries from aging. Confirming this could lead to novel ways to prevent cardiovascular diseases—a leading cause of death in Europe.

A pioneering approach involved studying how blood components affect artery health. Researchers exposed arteries from young and old mice, and later humans, to blood serum from various sources. They found that blood from older mice and humans tended to impair artery function, mimicking aging. Conversely, blood serum from young mice and humans improved artery health.

The most groundbreaking discovery came with blood serum from bottlenose dolphins. When arteries from old mice were incubated with serum from aging dolphins, their function remained surprisingly healthy. This suggested that dolphin blood retains youth-preserving factors even at advanced ages, a finding published in the American Journal of Physiology.

Future research aims to identify the specific molecules responsible for this protective effect. Collaborations are underway with experts studying arterial aging conditions, such as Marfan syndrome, to understand potential mechanisms. The goal is to pinpoint which factors in dolphin blood maintain arterial health and how to translate this knowledge into human therapies.

As research progresses, scientists plan larger international studies to confirm these promising results. Understanding how dolphins naturally prevent arterial aging may pave the way for new treatments to combat cardiovascular diseases and promote healthy aging in humans, potentially transforming cardiovascular medicine in the future.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

New Molecular Mechanism Uncovered in Childhood Brain Cancer

Researchers uncover a key molecular mechanism driving childhood brain cancer, revealing potential targeted therapies for Diffuse Midline Glioma.

Research Confirms Smoking Elevates Risk of Type 2 Diabetes Across All Subtypes

New research reveals that smoking significantly elevates the risk of developing all subtypes of type 2 diabetes, emphasizing the importance of quitting smoking for prevention.

Innovative Approaches Urged to Integrate Dentistry into Primary Care

Experts highlight the urgent need to embed dental health within primary care to improve disease prevention, manage chronic illnesses, and promote health equity through interprofessional collaboration and policy reforms.

Potential Benefits of GLP-1 Receptor Agonists in Managing Idiopathic Intracranial Hypertension

New research suggests that GLP-1 receptor agonists may improve outcomes in patients with idiopathic intracranial hypertension, offering a potential new treatment approach.